Light-activated Nanoparticle for Uveal Melanoma

https://www.aao.org/interview/light-activated-nanoparticle-therapy-uveal-melanom   In this interview from AAO 2019, Dr. Carol Shields discusses a new light-activated nanoparticle therapy (AU-011) for ocular melanoma. The particle, which is attached to a chromophore, binds to melanoma cells and is activated by a 689-nanometer light. Early-stage trials look promising, she explains, with preliminary results demonstrating minimal vision loss, suggesting this […]